Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets

单克隆抗体 血小板 抗体 表位 补体系统 免疫学 人类白细胞抗原 经典补体途径 抗原 多克隆抗体 化学 糖基化 生物 生物化学
作者
Thijs L.J. Van Osch,Janita J. Oosterhoff,Arthur E. H. Bentlage,Jan Nouta,Carolien A. M. Koeleman,Dionne M. Geerdes,Juk Yee Mok,Sebastiaan Heidt,Arend Mulder,Wim J. E. Van Esch,Rick Kapur,Leendert Porcelijn,C. Ellen Van der Schoot,Masja De Haas,Manfred Wuhrer,Jan Voorberg,Gestur Vidarsson
出处
期刊:Haematologica [Ferrata Storti Foundation]
卷期号:107 (10): 2432-2444 被引量:1
标识
DOI:10.3324/haematol.2021.280493
摘要

Approximately 20% of patients receiving multiple platelet transfusions develop platelet alloantibodies, which can be directed against human leukocyte antigens (HLA) and, to a lesser extent, against human platelet antigens (HPA). These antibodies can lead to the rapid clearance of donor platelets, presumably through IgG-Fc receptor (FcγR)-mediated phagocytosis or via complement activation, resulting in platelet refractoriness. Strikingly, not all patients with anti-HLA or -HPA antibodies develop platelet refractoriness upon unmatched platelet transfusions. Previously, we found that IgG Fc glycosylation of anti-HLA antibodies was highly variable between patients with platelet refractoriness, especially with respect to galactosylation and sialylation of the Fc-bound sugar moiety. Here, we produced recombinant glycoengineered anti-HLA and anti- HPA-1a monoclonal antibodies with varying Fc galactosylation and sialylation levels and studied their ability to activate the classical complement pathway. We observed that anti-HLA monoclonal antibodies with different specificities, binding simultaneously to the same HLA-molecules, or anti-HLA in combination with anti-HPA-1a monoclonal antibodies interacted synergistically with C1q, the first component of the classical pathway. Elevated Fc galactosylation and, to a lesser extent, sialylation significantly increased the complement-activating properties of anti-HLA and anti-HPA-1a monoclonal antibodies. We propose that both the breadth of the polyclonal immune response, with recognition of different HLA epitopes and in some cases HPA antigens, and the type of Fc glycosylation can provide an optimal stoichiometry for C1q binding and subsequent complement activation. These factors can shift the effect of a platelet alloimmune response to a clinically relevant response, leading to complement-mediated clearance of donor platelets, as observed in platelet refractoriness.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
绛橘色zy完成签到,获得积分10
刚刚
1秒前
妮妮发布了新的文献求助20
1秒前
2秒前
陌欣冉完成签到 ,获得积分10
2秒前
无情的谷兰完成签到,获得积分10
2秒前
espt发布了新的文献求助10
2秒前
波谷完成签到,获得积分10
3秒前
ZeroTwo完成签到 ,获得积分10
3秒前
3秒前
Allen完成签到,获得积分10
3秒前
4秒前
爆米花应助jfeng采纳,获得10
4秒前
机智若雁完成签到,获得积分10
4秒前
大茗星发布了新的文献求助10
4秒前
my完成签到 ,获得积分10
5秒前
桃桃完成签到,获得积分20
7秒前
LIMING发布了新的文献求助10
8秒前
Kao应助陈思采纳,获得10
9秒前
领导范儿应助jkhjkhj采纳,获得10
9秒前
阿伟爱打球完成签到,获得积分10
10秒前
11秒前
无情依霜完成签到,获得积分10
11秒前
传奇3应助小毛竹采纳,获得10
12秒前
传奇3应助科研通管家采纳,获得10
12秒前
领导范儿应助科研通管家采纳,获得10
12秒前
espt完成签到,获得积分10
13秒前
lizishu应助科研通管家采纳,获得10
13秒前
LihuaLu0417发布了新的文献求助10
13秒前
aaaa应助科研通管家采纳,获得10
13秒前
ding应助科研通管家采纳,获得10
13秒前
applecat147完成签到,获得积分10
13秒前
NexusExplorer应助科研通管家采纳,获得10
13秒前
aaaa应助科研通管家采纳,获得10
13秒前
彭于晏应助科研通管家采纳,获得10
13秒前
13秒前
yl666应助科研通管家采纳,获得10
13秒前
荣容应助科研通管家采纳,获得10
13秒前
aaaa应助科研通管家采纳,获得10
13秒前
Owen应助科研通管家采纳,获得30
14秒前
高分求助中
Principles of Economics, 11th Edition 10000
Prescott's Microbiology: 2026 Release ISE 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Interactions of Vowel Quality and Prosody in East Slavic 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7188003
求助须知:如何正确求助?哪些是违规求助? 8825775
关于积分的说明 18635113
捐赠科研通 6819670
什么是DOI,文献DOI怎么找? 3174043
关于科研通互助平台的介绍 2324233
邀请新用户注册赠送积分活动 2148501